Jul 2026 (Q3 FY26) — Aug 19, 2026
Analog Devices Q3 FY26 — Record Revenue and Strong AI-Driven Growth
Read the full callAnalog Devices earnings: last reported Wed, 19 Aug 2026, for the quarter ended Jul 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 4,022 | +39.6% YoY | Quarterly, as filed | Quarter to Aug 2026 | Revenue from operations as filed. |
| Operating margin | 40.1 | +11.7 pts YoY | Operating profit / revenue | Quarter to Aug 2026 | For the quarter; a change is in percentage points. |
| Net profit | 1,340 | +158.4% YoY | Quarterly, as filed | Quarter to Aug 2026 | Profit after tax as filed. |
Guidance
64 of 72 judged targets kept · 13 open · verdicts reflect calls analysed to Jul 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Automotive revenue growth (sequential) | mid- to high single digits | Apr 2026 | Automotive represented 25% of revenue, finishing up 14% sequentially and 16% year-over-year. | Achieved |
| Automotive revenue growth | grow in fiscal '26 | Jan 2026 | Automotive represented 25% of revenue, finishing up 14% sequentially and 16% year-over-year. Our higher content and share positions globally continue to result in growth well above SAAR. | On Track |
8 of ANALOG DEVICES INC's 85 targets were missed. See which ones, and which are quietly gone. The 2 above are the free sample; 83 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $242.87 on 17 Oct 2025 → $394.35. High $445.48 (22 Jun 2026), low $225.2 (20 Nov 2025).
Overview
Guidance
64 of 72 judged targets kept · 13 open · verdicts reflect calls analysed to Jul 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Automotive revenue growth (sequential) | mid- to high single digits | Apr 2026 | Automotive represented 25% of revenue, finishing up 14% sequentially and 16% year-over-year. | Achieved |
| Automotive revenue growth | grow in fiscal '26 | Jan 2026 | Automotive represented 25% of revenue, finishing up 14% sequentially and 16% year-over-year. Our higher content and share positions globally continue to result in growth well above SAAR. | On Track |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 85 tracked commitments, with each call’s wording and source.
Call summaries
Analog Devices Q3 FY26 — Record Revenue and Strong AI-Driven Growth
Read the full callAnalog Devices Q2 FY26 — record $3.62B revenue and $3.09 EPS on broad-based industrial and data-center strength
Read the full callAnalog Devices Q1 FY26 — Strong Growth Across Key Markets, Raised Dividend, and Robust AI-Driven Demand
Read the full callEvery analysed call
Financials
Net profit, year on year: +158% (quarter to aug 2026 against aug 2025).
| Line item | Nov 2024 | Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Jan 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,443 | 2,423 | 2,640 | 2,880 | 3,076 | 3,160 | 3,623 | 4,022 |
| Operating profit | 569 | 491 | 678 | 818 | 945 | 997 | 1,380 | 1,613 |
| Operating margin | 23.3% | 20.3% | 25.7% | 28.4% | 30.7% | 31.6% | 38.1% | 40.1% |
| Other income | -53 | -56 | -52 | -55 | -58 | -51 | -55 | -67 |
| Interest | 83 | 75 | 75 | 80 | 88 | 86 | 88 | 89 |
| Profit before tax | 516 | 436 | 626 | 763 | 887 | 946 | 1,325 | 1,546 |
| Tax rate | 7.4% | 10.2% | 9.0% | 32.1% | 11.2% | 12.2% | 11.2% | 13.3% |
| Net profit | 478 | 391 | 570 | 519 | 788 | 831 | 1,176 | 1,340 |
| EPS ($ per share) | — | 0.79 | 1.15 | 1.05 | — | 1.70 | 2.41 | 2.76 |
| Line item | Nov 2018 | Nov 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 62 | 61 | 62 | 88 | 85 | 83 | 83 | 82 |
| Reserves | 5,983 | 6,899 | 7,236 | 7,517 | 8,721 | 10,357 | 10,197 | 10,540 |
| Total liabilities | 9,170 | 9,683 | 9,471 | 14,330 | 13,837 | 13,229 | 13,052 | 14,177 |
| Fixed assets | 1,154 | 1,220 | 1,121 | 1,979 | 2,401 | 3,219 | 3,416 | 3,316 |
| Investments | — | — | — | — | — | 0 | 372 | 1,153 |
| Total assets | 20,438 | 21,393 | 21,469 | 52,322 | 50,302 | 48,794 | 48,228 | 47,993 |
| Line item | Nov 2018 | Nov 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2,442 | 2,253 | 2,008 | 2,735 | 4,475 | 4,818 | 3,853 | 4,812 |
| Cash from investing | -314 | -293 | -181 | 2,144 | -657 | -1,266 | -1,105 | -1,322 |
| Cash from financing | -2,358 | -2,127 | -1,421 | -3,960 | -4,291 | -4,064 | -1,714 | -2,983 |
| Net cash flow | -231 | -168 | 408 | 922 | -507 | -513 | 1,033 | 508 |
| Capital expenditure | -255 | -275 | -166 | -344 | -699 | -1,261 | -730 | -534 |
| Free cash flow | 2,187 | 1,978 | 1,843 | 2,391 | 3,776 | 3,556 | 3,122 | 4,279 |
| Segment | Q3 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Reportable | — | — | — | — | — | 100% | 100% | 100% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
269 filings between Nov 3, 2025 and Oct 12, 2026.
Purchases
None
No insider bought shares.
Sales
$104.63M
205 sales by 8 insiders
92% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 3 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| ROCHE VINCENT | — | $65.12M | Oct 1, 2026 |
| STATA RAY | — | $14.93M | Oct 7, 2026 |
| Cotter Martin | — | $11.49M | Jun 2, 2026 |
| Jain Vivek | — | $4.57M | Oct 8, 2026 |
| Sondel Michael | — | $3.80M | Feb 25, 2026 |
| Puccio Richard C Jr | — | $2.76M | Oct 6, 2026 |
| Golz Karen | — | $1.18M | Aug 27, 2026 |
| Nakamura Katsufumi | — | $793.3K | Oct 2, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | ROCHE VINCENT Chair & CEO | Gift | 13,305 | $0 |
| Oct 8, 2026 | Jain Vivek Chief Operations/Tech Officer | Sale | 3,305 | $1.34M |
| Oct 7, 2026 | Jain Vivek Chief Operations/Tech Officer | Sale | 2,000 | $819.6K |
| Oct 7, 2026 | STATA RAY Director | Sale 10b5-1 plan | 26 | $10.7K |
| Oct 7, 2026 | STATA RAY Director | Sale 10b5-1 plan | 234 | $96.0K |
| Oct 7, 2026 | STATA RAY Director | Sale 10b5-1 plan | 65 | $26.7K |
| Oct 7, 2026 | STATA RAY Director | Sale 10b5-1 plan | 228 | $92.9K |
| Oct 7, 2026 | STATA RAY Director | Sale 10b5-1 plan | 482 | $195.9K |
| Oct 7, 2026 | STATA RAY Director | Sale 10b5-1 plan | 333 | $135.1K |
| Oct 7, 2026 | STATA RAY Director | Sale 10b5-1 plan | 48 | $19.6K |
| Oct 6, 2026 | STATA RAY Director | Sale 10b5-1 plan | 702 | $295.1K |
| Oct 6, 2026 | STATA RAY Director | Sale 10b5-1 plan | 428 | $179.5K |
| Oct 6, 2026 | STATA RAY Director | Sale 10b5-1 plan | 186 | $78.4K |
| Oct 6, 2026 | STATA RAY Director | Sale 10b5-1 plan | 100 | $41.8K |
| Oct 6, 2026 | Puccio Richard C Jr Chief Financial Officer | Sale 10b5-1 plan | 1,500 | $631.6K |
| Oct 2, 2026 | Jain Vivek Chief Operations/Tech Officer | Sale | 2,000 | $834.0K |
| Oct 2, 2026 | Nakamura Katsufumi Chief Customer Officer | Sale | 1,200 | $498.0K |
| Oct 1, 2026 | ROCHE VINCENT Chair & CEO | Sale 10b5-1 plan | 10,000 | $3.97M |
| Oct 1, 2026 | ROCHE VINCENT Chair & CEO | Option exercise 10b5-1 plan | 10,000 | $1.08M |
| Sep 22, 2026 | Puccio Richard C Jr Chief Financial Officer | Sale 10b5-1 plan | 1,500 | $573.3K |
| Sep 18, 2026 | ROCHE VINCENT Chair & CEO | Gift | 19,200 | $0 |
| Sep 9, 2026 | STATA RAY Director | Sale 10b5-1 plan | 72 | $26.4K |
| Sep 9, 2026 | STATA RAY Director | Sale 10b5-1 plan | 461 | $167.8K |
| Sep 9, 2026 | STATA RAY Director | Sale 10b5-1 plan | 158 | $57.2K |
| Sep 9, 2026 | STATA RAY Director | Sale 10b5-1 plan | 369 | $133.9K |
| Sep 9, 2026 | STATA RAY Director | Sale 10b5-1 plan | 356 | $129.9K |
| Sep 8, 2026 | STATA RAY Director | Sale 10b5-1 plan | 200 | $72.9K |
| Sep 8, 2026 | STATA RAY Director | Sale 10b5-1 plan | 222 | $80.7K |
| Sep 8, 2026 | STATA RAY Director | Sale 10b5-1 plan | 156 | $57.0K |
| Sep 8, 2026 | STATA RAY Director | Sale 10b5-1 plan | 12 | $4.4K |
| Sep 8, 2026 | STATA RAY Director | Sale 10b5-1 plan | 364 | $131.5K |
| Sep 8, 2026 | STATA RAY Director | Sale 10b5-1 plan | 462 | $167.3K |
| Sep 8, 2026 | Puccio Richard C Jr EVP and CFO | Sale 10b5-1 plan | 1,500 | $545.5K |
| Sep 1, 2026 | ROCHE VINCENT Chair & CEO | Sale 10b5-1 plan | 10,000 | $3.56M |
| Sep 1, 2026 | ROCHE VINCENT Chair & CEO | Option exercise 10b5-1 plan | 10,000 | $1.08M |
| Aug 27, 2026 | Golz Karen Director | Sale 10b5-1 plan | 1,000 | $374.5K |
| Aug 26, 2026 | Puccio Richard C Jr EVP and CFO | Sale 10b5-1 plan | 2,683 | $1.00M |
| Aug 17, 2026 | Jain Vivek EVP, Global Operations | Tax withheld | 1,111 | $433.6K |
| Aug 17, 2026 | Cotter Martin SVP, Vertical Business Units | Tax withheld | 705 | $275.1K |
| Aug 17, 2026 | Nakamura Katsufumi SVP, Chief Customer Officer | Tax withheld | 202 | $78.7K |
| Aug 17, 2026 | Puccio Richard C Jr EVP and CFO | Tax withheld | 1,108 | $432.5K |
| Aug 17, 2026 | ROCHE VINCENT Chair & CEO | Tax withheld | 2,878 | $1.12M |
| Aug 17, 2026 | Sondel Michael CAO (principal acct. officer) | Tax withheld | 237 | $92.7K |
| Aug 5, 2026 | STATA RAY Director | Sale 10b5-1 plan | 28 | $10.7K |
| Aug 5, 2026 | STATA RAY Director | Sale 10b5-1 plan | 86 | $32.8K |
| Aug 5, 2026 | STATA RAY Director | Sale 10b5-1 plan | 116 | $44.2K |
| Aug 5, 2026 | STATA RAY Director | Sale 10b5-1 plan | 229 | $86.9K |
| Aug 5, 2026 | STATA RAY Director | Sale 10b5-1 plan | 373 | $141.2K |
| Aug 5, 2026 | STATA RAY Director | Sale 10b5-1 plan | 271 | $102.3K |
| Aug 5, 2026 | STATA RAY Director | Sale 10b5-1 plan | 237 | $89.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow ANALOG DEVICES INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading